Maven integrates oncofertility into cancer care

This partnership shows how Maven is turning fertility from a standalone benefit into a care coordination layer that can sit inside other expensive medical journeys. Instead of only helping when someone is planning pregnancy, Maven now plugs into the moment a cancer diagnosis threatens future fertility, while Color handles oncology navigation and Maven handles preservation counseling, referrals, and benefit workflows through the same employer and health plan channels.1 2 3 4 5

• In practice, the handoff is simple. Color flags cancer patients whose treatment may affect fertility, then routes them into Maven’s oncofertility pathway. Members get virtual access to oncologists, fertility preservation specialists, mental health support, and guidance on options like egg, sperm, and embryo freezing before treatment starts.2 3 6
• The strategic value is distribution leverage. Maven already sells family and fertility benefits to employers and health plans, with 17 million plus covered lives and an asset light provider marketplace. Adding oncofertility opens a new use case without building cancer care infrastructure from scratch, because Color already sells an oncologist led virtual cancer clinic into those same buyers.4 5 7 8
• This also sharpens Maven’s position against fertility benefit rivals. Progyny and Maven both work through employer contracts and clinic networks, while Kindbody owns clinics and IVF labs. Oncofertility favors Maven’s model because the hard part is fast coordination across oncology, benefits, and outside fertility providers, not owning the procedure site.4 7 9

The next step is for employer fertility benefits to look more like condition specific care pathways, where preservation, treatment navigation, and reimbursement sit in one flow instead of three separate vendors. If Maven keeps layering specialized pathways like oncofertility onto its existing buyer base, it moves closer to becoming the default operating system for reproductive health benefits.1 4 5 7